You searched for Parkinson's - Page 5 of 20 - Labiotech.eu

parkinsons disease treefrog therapeutics cell therapy

News and Trends 9 Jun 2020

French Manufacturing Plant Launches to Make Cell Therapy Cheap and Scalable

…the development of in-house cell therapies for conditions such as Parkinson’s disease and heart failure. The new plant will also allow Treefrog to produce cell therapies for at least two…

June 9, 2020 - 4 minutesmins - By Jonathan Smith

Neuroscience companies

Best in Biotech 15 Aug 2024

10 neuroscience biotech companies you should know about

…the progression of debilitating neurodegenerative conditions, including Alzheimer’s, FTD, and Parkinson’s disease. To try and achieve this, it has a drug discovery platform that combines high-resolution target structural approaches, artificial…

August 15, 2024 - 12 minutesmins - By Willow Shah-Neville

shutterstock 746879377

More News! 27 Jun 2019

German Biotech Will Target Parkinsonian Disorders with €12M Series A

…is a rare disorder, with similar symptoms to Parkinson’s disease, that is caused by breakdown of neurons in parts of the brain. The German biotech’s drug candidate prevents and stops…

June 27, 2019 - 2 minutesmins - By Helen Albert

Biotech companies in New York

Best in Biotech 3 Oct 2023

Five impactful biotech companies to know in New York

…depression, Parkinson’s disease, and behavioral disturbances associated with Alzheimer’s disease. The company was founded on Dr. Paul Greengard’s Nobel Prize-winning research, which uncovered how therapies affect the inner workings of…

October 3, 2023 - 8 minutesmins - By Willow Shah-Neville

ADVERTISEMENT

Biotech investment january 2024

2024 biotech funding tracker: recent highlights

…AI-enabled vaccine platform | Preclinical in coronavirus March 2024: Kenai Therapeutics (USA): $82 million series A | stem cell therapy | preclinical in moderate to severe Parkinson’s disease. Tierra Biosciences…

February 23, 2024 - 1 minutemin - By Aurore Michelin

Neurodegenerative Cover

News and Trends 14 Sep 2022

Collaboration to explore gene therapy products for neurodegenerative disorders

…development of gene therapy products targeting the transcription factor EB (TFEB) for the treatment of alpha-synucleinopathies, such as Multiple System Atrophy (MSA) and idiopathic Parkinson’s disease (PD). Toxic protein aggregates…

September 14, 2022 - 3 minutesmins - By Liza Laws

treefrog therapeutics cell therapy parkinsons disease

News and Trends 13 May 2019

Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks

…the Series A money will help Treefrog to automate its stem cell production process by 2021. The round will also fund the development of a stem cell therapy for Parkinson’s…

May 13, 2019 - 3 minutesmins - By Jonathan Smith

axovant sciences dementia bermuda

News and Trends 13 Feb 2017

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

…Parkinson’s disease dementia (PDD). Based on these positive preliminary results, the biotech is getting ready to recruit more patients and prepare for Phase III, which is expected to start in…

February 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Estonia biotech companies

Best in Biotech 17 Sep 2024

Estonia: Seven biotech companies to reckon with

…RNA modifications to address these diseases. The company’s lead drug candidate, CHMA1004, is currently in the preclinical stage and is being developed to treat Parkinson’s disease, depression, anxiety, and post-traumatic…

September 17, 2024 - 7 minutesmins - By Jules Adam

Theranexus IPO CNS Narcolepsy Parkinsons Alzheimers

News and Trends 30 Oct 2017

French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s

Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline of CNS drugs for narcolepsy, Parkinson’s, Alzheimer’s and neuropathic pain. Theranexus, based in Lyon, starts…

October 30, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

crystal light

In Depth 31 Jan 2017

Biologicals on the Brain: Biotech in Neurodegenerative Disease

…Phase II trials and AFFiRiS, a Vienna-based biotech that currently has a Parkinson’s vaccine in a Phase 1b trial. “Our therapeutic is aimed at teaching the body to produce the…

January 31, 2017 - 7 minutesmins - By Diana Kwon

geneva biotech serono university of geneva

Best in Biotech 30 May 2017

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

…Swiss Exchange, works in a mostly virtual biotech model and is carrying on clinical programs on Parkinson’s Disease and epilepsy with some high-profile partnerships, including Janssen and the Michael J….

May 30, 2017 - 7 minutesmins - By Denise Neves Gameiro